A group of 11 Premier Inc. member health systems are set to have uninterrupted supply of 19 pharmaceutical products in the US, including several shortage-hit generic injectables, after the US-based hospital group purchasing organization and its health systems acquired a minority stake in the holding company of generic injectables specialist Exela Pharma Sciences.
As part of the investment, the participating health systems have signed multi-year commitments to purchase a portion of their pharmaceutical products from Exela through Premier’s group purchasing organization. Premier members...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?